Oberzent (DE)
{name}
{subtitle}
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-small Cell Lung Cancer
city
~23 mi. (Heidelberg, Germany, +151 more cities)
facility
GSK Investigational Site
condition
Non-Small Cell Lung Carcinoma
drug
niraparib, +1 more drug
drug type
immunotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~23 mi. (Heidelberg, Germany, +145 more cities)
facility
Universitaetsklinikum Heidelberg. ( Site 1204)
condition
Non-Small Cell Lung Carcinoma
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~23 mi. (Heidelberg, Germany, +127 more cities)
facility
Universitaetsklinik Heidelberg /ID# 216623
condition
Acute Myeloid Leukemia
drug
azacitidine, +2 more drugs
drug type
chemotherapy
Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma
city
~23 mi. (Heidelberg, Germany, +54 more cities)
facility
Universitaetsklinik Heidelberg /ID# 229145
condition
Multiple Myeloma
drug
carfilzomib, +4 more drugs
drug type
chemotherapy, +3 more types